Table 2.
Studies of primary TKAs reporting no significant male-female differences
| Study | Total TKAs | Males | Females | Male knees | Female knees | Followup (years) | Criteria | Result: male/female difference |
|---|---|---|---|---|---|---|---|---|
| Scuderi et al. [35], 1989 | 1430 | NNG | NNG | 445 | 985 | 2–15 | Implant survivorship | No significant difference |
| Whiteside [37], 1991 | 724 | NNG | NNG | 339 | 385 | 2 | Pain relief | No significant difference |
| Font-Rodriguez et al. [13], 1997 | 2629 | NNG | NNG | 789 | 1840 | 2–22 | Implant survivorship | No significant difference |
| Gill and Joshi [14], 2001 | 404 | 120 | 208 | NNG | NNG | 2–17 | Implant survivorship | No significant difference |
| Khaw et al. [24], 2002 | 501 | 172 | 224 | NNG | NNG | 3–13 | Implant survivorship | No significant difference |
| Kim et al. [25], 2004 | 1000 | 337 | 644 | NNG | NNG | 3 | Stiffness | No significant difference |
| Wright et al. [39], 2004 | 523 | 130 | 277 | NNG | NNG | 2–15 | Outcome scores | No significant difference |
| Kane et al. [23], 2005 (meta-analysis of 62 studies) | > 100 per study | 34.6% | 65.4% | NNG | NNG | Variable or no data | Outcome scores | No significant difference |
| Bourne et al. [7], 2007 | 843 | 292 | 436 | NNG | NNG | 5–11 | Outcome scores | No significant difference |
NNG = number not given.